3.7.2025 09:01:35 CEST | Aqua Bio Technology ASA | Additional regulated information required to be disclosed under the laws of a member state
An extraordinary general meeting of Aqua Bio Technology ASA (the “Company” or”ABTEC”) will be held on 25 July 2025 at 11:00 (CET) at ABT´s office in Bygdøy Alle 3, Oslo. Please find attached the notice to the general meeting. All documents to be treated at the meeting will be made available at the Company’s website www.aquabiotechnology.com – http://www.aquabiotechnology.com – http://www.aquabiotechnology.com.Shareholders who wish to the attend the general meeting is requested to notifythe Company as set out in Appendix 2 to the notice within 23 July 2025 at 16:00(CET). In case of attendance by proxy, the proxy form (also included in appendix2 to the notice) is requested submitted to be received by the Company within thesame date.
Disclosure regulation
This information is subject of the disclosure requirements pursuant to section of 5-12 of the Norwegian Securities Trading Act.
Contacts
Roger Sedal, Chair of the Board of Directors, Aqua Bio Technology ASA, +4740002002, roger@sedal.no
Terje Blytt, JetCarrier AS, +4769184030
About Aqua Bio Technology ASA
Aqua Bio Technology ASA (ABT) is a distribution group in skincare and nonfood. The group has distribution towards B2C, B2B, B2B2, and freight, customs, and logistics services. The group also develops sustainable biotechnology for use in skincare products. Aqua Bio Technology is listed on the Euronext Expand market of the Oslo Stock Exchange.
Attachments
Download announcement as PDF.pdf
WEB Aqua Bio Technology.pdf
